<?xml version="1.0" encoding="utf-8"?>
<rdf:Description rdf:about="https://catalogues.royalsociety.org:443/CalmView/record/catalog/HF/1/14/3/2/52" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <dc:title>Letter from Agustin Arriagada, Santiago, Chile to Howard Walter Florey</dc:title>
  <dc:description>Thanks for reprints on bacitracin - clear that ayfivin (Bacitracin) will never be used for general therapeutics - comments on this - wants to know why name bacitracin has been adopted in place of ayfivin, which he worked on in 944 and called subtilin - discusses this - is sending summary of work on effects of temperature of 42 degrees celsius on tubercle bacilli and on antibiotic activity - wonders if radioactive isotopes might be used in culture media to obtain different kinds of antibacterial substances from bacteria - comments on this.</dc:description>
  <dc:date>1 April 1952</dc:date>
</rdf:Description>